Novozymes A/S
NSIS-B
株式のランク
#821
Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global... Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global provider of biological solutions, specializing in the development and sale of industrial enzymes, microorganisms, and probiotics. The company's reach extends internationally, serving markets in Denmark, the rest of Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America. Novozymes' diverse portfolio includes protein solutions for the food and beverage sector, alongside a comprehensive suite of cleaning and hygiene offerings for industrial, medical, and household applications, such as drain openers, septic tank treatments, ware washing, and professional laundry. In agriculture, they supply solutions for various crops like corn, cotton, soybeans, and wheat, focusing on bioyield and biocontrol, in addition to animal health and nutrition products and aquaculture systems for warm water species. The company actively supports sustainable industrial processes with contributions to bioenergy (including ethanol, biodiesel, renewable diesel, biogas, and wastewater treatment), biorefining (encompassing fiber modification, bleach boosting, deposit control, starch modification, carbon capture), and applications for textiles and leather. Their extensive range of enzyme solutions, such as lipases, proteases, oxidoreductases, and carbohydrases, are crucial for processes like corn and wheat separation, liquefaction, and saccharification. Furthermore, Novozymes addresses human health with solutions targeting brain, oral, protective, immune, and gastrointestinal well-being, while also engaging in areas like biocatalysis, cell culture, and diagnostics.
株価
$71.08
時価総額
$29.32B
変化（1日）
1.13%
変化（1年）
11.94%
国
DK
取引 Novozymes A/S (NSIS-B)
カテゴリー
Basic Materials
Novozymes A/S（NSIS-B）の収益
Oct 2026 時点の収益 TTM: 0
Novozymes A/S の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Novozymes A/S の収益履歴（2002 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2025 | $4.87B | 22.29% |
| 2024 | $3.99B | 50.41% |
| 2023 | $2.65B | 681.55% |
| 2022 | $339.08M | 10.30% |
| 2021 | $307.42M | -86.63% |
| 2020 | $2.30B | 6.62% |
| 2019 | $2.16B | -2.39% |
| 2018 | $2.21B | -5.63% |
| 2017 | $2.34B | 16.67% |
| 2016 | $2.01B | -1.63% |
| 2015 | $2.04B | 0.69% |
| 2014 | $2.03B | -6.45% |
| 2013 | $2.17B | 9.03% |
| 2012 | $1.99B | 707.80% |
| 2011 | $245.94M | -85.90% |
| 2010 | $1.74B | 6.91% |
| 2009 | $1.63B | 7.12% |
| 2008 | $1.52B | 677.27% |
| 2007 | $195.91M | -83.68% |
| 2006 | $1.20B | 20.74% |
| 2005 | $994.18M | -9.18% |
| 2004 | $1.09B | 11.33% |
| 2003 | $983.27M | 23.47% |
| 2002 | $796.36M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $35.45B | - |
GB
|
|
| - | - |
FR
|
|
| $24.41B | - |
US
|
|
| $16.84B | - |
US
|
|
| $12.60B | - |
US
|
